Prostate cancer

What Is Prostate Cancer?

Prostate cancer develops when abnormal cells within the prostate gland, a small gland located below the bladder in men responsible for producing part of the fluid found in semen, begin growing uncontrollably.¹

Prostate cancer risk rises dramatically with age, climbing from a probability of roughly zero point zero zero five percent in men younger than thirty nine years old to two point two percent in men between forty and fifty nine, and nearly fourteen percent in men between sixty and seventy nine years of age.¹

Because many prostate cancers grow very slowly and may never cause symptoms or become life threatening, treatment decisions often involve carefully weighing the potential benefits of intervention against the possibility of overtreatment for cancers that would otherwise never have caused harm.²

Prostate cancer etiology is multifactorial with well established risk factors including advanced age, positive family history, and African ancestry.
National Center for Biotechnology Information

Symptoms

Prostate cancer symptoms often closely resemble those of benign prostatic hyperplasia, a common, noncancerous enlargement of the prostate, including frequent urination and increased nighttime urination.²

Additional urinary symptoms can include difficulty starting or maintaining a steady urine stream, blood in the urine, and painful urination, all reflecting the prostate’s close anatomical relationship to the urinary tract.²

Prostate cancer can also affect sexual function, sometimes causing difficulty achieving an erection or painful ejaculation, symptoms that patients may find particularly sensitive to discuss but that remain important to report to a healthcare provider.²

Causes

The precise cause of prostate cancer is not fully understood, though the disease is believed to arise from an accumulation of genetic changes within prostate cells over time, occurring more frequently as men age.¹

Elevated levels of prostate specific antigen, a substance measured through PSA testing, have been linked to factors including unhealthy lifestyle patterns, obesity, insufficient exercise, and chronic inflammation, though these associations do not necessarily establish direct causation of cancer itself.¹

The specific roles of smoking, alcohol use, diet, and physical activity as direct causes of prostate cancer remain somewhat unclear, with research findings on these factors described as equivocal or inconsistent across different studies.¹

Risk Factors

Advanced age represents the single strongest risk factor for prostate cancer, with incidence rising sharply throughout a man’s life, particularly after age sixty.¹

A positive family history of prostate cancer meaningfully raises individual risk, reflecting an underlying genetic component to the disease.¹

African ancestry has also been identified as a well established risk factor for prostate cancer, with affected men experiencing both higher incidence and, in some cases, more aggressive disease compared to men of other backgrounds.¹

Complications

PSA based screening, while helpful for detecting some cancers earlier, produces only a modest reduction in prostate cancer mortality over a ten year period, reflecting the complex tradeoffs involved in prostate cancer screening decisions.²

Because some cancers identified through PSA screening grow so slowly that they would never become life threatening, treating them can expose patients to unnecessary harm without providing meaningful benefit.²

Prostate biopsy, often performed to confirm a suspicious PSA result, carries its own risk of complications, including fever, pain, blood in the urine or semen, and urinary tract infection.²

Treatment

Active surveillance represents an important treatment option for many men with lower risk prostate cancer, involving regular physical examination, PSA monitoring, and periodic rebiopsy rather than immediate intervention, allowing complications of more aggressive treatment to be delayed or avoided entirely.³

For men who require active treatment, radical prostatectomy, involving surgical removal of the prostate gland, and radiation therapy both represent standard treatment options, with radiation sometimes given after surgery or combined with hormone therapy depending on individual risk factors.³

Androgen deprivation therapy works by reducing or blocking the male hormones that can drive prostate cancer growth, and for men with higher risk disease, combining this hormone therapy with radiation has been shown through randomized trials to provide meaningful additional benefit.³

Prevention

Because the precise causes of prostate cancer remain incompletely understood, there is no guaranteed way to prevent the disease from developing.

Maintaining a healthy body weight and staying physically active may help support overall prostate health, though evidence regarding their direct effect on prostate cancer risk specifically remains somewhat mixed.¹

For men with a family history of prostate cancer or other elevated risk factors, discussing individualized screening timelines with a healthcare provider allows for a more informed, personalized approach to early detection.²

Why Visual Communication Matters for Prostate Cancer

Explaining the tradeoffs involved in prostate cancer screening and treatment, including when active surveillance may be preferable to immediate intervention, requires visuals that help men understand these nuanced decisions clearly.

Pharmaceutical companies, urology and oncology practices, and patient education organizations rely on clear illustration and animation to explain prostate cancer biology and support informed treatment decisions.

• Illustrating prostate anatomy and its relationship to the urinary tract
• Animating how PSA testing and biopsy are used in prostate cancer diagnosis
• Explaining active surveillance, surgery, radiation, and hormone therapy options
• Visualizing the mechanism of action of androgen deprivation therapy
• Supporting patient education on personalized screening decisions
• Creating training materials for urology and oncology clinicians

How Biotic Artlab Supports Prostate Cancer Communication

We work with pharmaceutical companies, urology and oncology practices, and patient advocacy organizations to create scientifically accurate visuals that make prostate cancer and its treatment easier to understand.

• Custom 3D animations of prostate anatomy and cancer development
• Detailed illustrations of radical prostatectomy and radiation therapy techniques
• Mechanism of action animations for androgen deprivation therapy
• Patient facing materials comparing active surveillance and active treatment options
• Clinical training content for urology and oncology teams
• Conference presentations and marketing visuals for genitourinary cancer audiences

Frequently Asked Questions

What is the biggest risk factor for prostate cancer?

Advanced age represents the strongest risk factor, with incidence rising sharply as men grow older, particularly after age sixty.¹

What are common symptoms of prostate cancer?

Frequent urination, difficulty with urine flow, blood in the urine, and sexual dysfunction are common symptoms, though they often overlap with noncancerous prostate conditions.²

What is active surveillance?

Active surveillance involves regular monitoring through examinations, PSA testing, and periodic biopsy rather than immediate treatment, appropriate for many men with lower risk prostate cancer.³

Does PSA screening save lives?

PSA screening provides only a modest reduction in prostate cancer mortality over ten years, and some cancers detected would never have become life threatening.²

What is androgen deprivation therapy?

It is a hormone based treatment that reduces or blocks male hormones that can drive prostate cancer growth, often combined with radiation for higher risk disease.³

Is prostate cancer more common in certain groups?

Yes, African ancestry and a family history of prostate cancer are both well established risk factors associated with higher incidence.¹

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to prostate cancer or genitourinary oncology, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. The Etiology of Prostate Cancer.
2. National Cancer Institute. Prostate Cancer Screening.
3. National Cancer Institute. Prostate Cancer Treatment.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.